

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | epoxygenase P450 pathway (GO:0019373) | 5.21246729 |
| 2 | exogenous drug catabolic process (GO:0042738) | 5.13446762 |
| 3 | negative regulation of fibrinolysis (GO:0051918) | 5.04910704 |
| 4 | complement activation, alternative pathway (GO:0006957) | 4.99871600 |
| 5 | drug catabolic process (GO:0042737) | 4.87802785 |
| 6 | regulation of protein activation cascade (GO:2000257) | 4.79252293 |
| 7 | regulation of fibrinolysis (GO:0051917) | 4.77101800 |
| 8 | L-phenylalanine catabolic process (GO:0006559) | 4.63791408 |
| 9 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.63791408 |
| 10 | regulation of complement activation (GO:0030449) | 4.56371604 |
| 11 | phospholipid efflux (GO:0033700) | 4.49686948 |
| 12 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.48715118 |
| 13 | regulation of cholesterol esterification (GO:0010872) | 4.39337619 |
| 14 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.37219671 |
| 15 | L-phenylalanine metabolic process (GO:0006558) | 4.37219671 |
| 16 | glyoxylate metabolic process (GO:0046487) | 4.36296601 |
| 17 | regulation of triglyceride catabolic process (GO:0010896) | 4.33775415 |
| 18 | omega-hydroxylase P450 pathway (GO:0097267) | 4.29406362 |
| 19 | ethanol oxidation (GO:0006069) | 4.26373013 |
| 20 | positive regulation of lipoprotein lipase activity (GO:0051006) | 4.22508583 |
| 21 | positive regulation of triglyceride lipase activity (GO:0061365) | 4.22508583 |
| 22 | protein carboxylation (GO:0018214) | 4.21366154 |
| 23 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.21366154 |
| 24 | negative regulation of cholesterol transport (GO:0032375) | 4.15081640 |
| 25 | negative regulation of sterol transport (GO:0032372) | 4.15081640 |
| 26 | urea metabolic process (GO:0019627) | 4.14128372 |
| 27 | nitrogen cycle metabolic process (GO:0071941) | 3.93380946 |
| 28 | high-density lipoprotein particle remodeling (GO:0034375) | 3.91950019 |
| 29 | protein-lipid complex remodeling (GO:0034368) | 3.85800689 |
| 30 | macromolecular complex remodeling (GO:0034367) | 3.85800689 |
| 31 | plasma lipoprotein particle remodeling (GO:0034369) | 3.85800689 |
| 32 | cholesterol efflux (GO:0033344) | 3.81126980 |
| 33 | plasma lipoprotein particle assembly (GO:0034377) | 3.76538123 |
| 34 | fibrinolysis (GO:0042730) | 3.71411947 |
| 35 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.70953842 |
| 36 | drug metabolic process (GO:0017144) | 3.68593975 |
| 37 | urea cycle (GO:0000050) | 3.68389763 |
| 38 | blood coagulation, intrinsic pathway (GO:0007597) | 3.67005258 |
| 39 | ethanol metabolic process (GO:0006067) | 3.47667552 |
| 40 | reverse cholesterol transport (GO:0043691) | 3.47080679 |
| 41 | plasma lipoprotein particle clearance (GO:0034381) | 3.45830642 |
| 42 | protein-lipid complex assembly (GO:0065005) | 3.44536788 |
| 43 | acute-phase response (GO:0006953) | 3.40009106 |
| 44 | protein activation cascade (GO:0072376) | 3.37938754 |
| 45 | regulation of humoral immune response (GO:0002920) | 3.34547111 |
| 46 | cellular glucuronidation (GO:0052695) | 3.31003140 |
| 47 | aromatic amino acid family catabolic process (GO:0009074) | 3.30756429 |
| 48 | plasma lipoprotein particle organization (GO:0071827) | 3.29107018 |
| 49 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.26091469 |
| 50 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.26091469 |
| 51 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.21637236 |
| 52 | low-density lipoprotein particle remodeling (GO:0034374) | 3.20291960 |
| 53 | complement activation (GO:0006956) | 3.20249218 |
| 54 | negative regulation of blood coagulation (GO:0030195) | 3.19307616 |
| 55 | negative regulation of hemostasis (GO:1900047) | 3.19307616 |
| 56 | bile acid biosynthetic process (GO:0006699) | 3.17658824 |
| 57 | acylglycerol homeostasis (GO:0055090) | 3.15471566 |
| 58 | triglyceride homeostasis (GO:0070328) | 3.15471566 |
| 59 | complement activation, classical pathway (GO:0006958) | 3.15265228 |
| 60 | glucuronate metabolic process (GO:0019585) | 3.14887361 |
| 61 | uronic acid metabolic process (GO:0006063) | 3.14887361 |
| 62 | protein-lipid complex subunit organization (GO:0071825) | 3.14526357 |
| 63 | regulation of plasminogen activation (GO:0010755) | 3.14522571 |
| 64 | * bile acid metabolic process (GO:0008206) | 3.13309745 |
| 65 | bile acid and bile salt transport (GO:0015721) | 3.12859838 |
| 66 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.11638921 |
| 67 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.10152523 |
| 68 | positive regulation of lipid catabolic process (GO:0050996) | 3.05358888 |
| 69 | positive regulation of blood coagulation (GO:0030194) | 3.04931623 |
| 70 | positive regulation of hemostasis (GO:1900048) | 3.04931623 |
| 71 | * fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.93193694 |
| 72 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.92972114 |
| 73 | negative regulation of protein activation cascade (GO:2000258) | 2.91031690 |
| 74 | detection of bacterium (GO:0016045) | 2.86412023 |
| 75 | positive regulation of coagulation (GO:0050820) | 2.86127089 |
| 76 | negative regulation of coagulation (GO:0050819) | 2.85939031 |
| 77 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.84777041 |
| 78 | negative regulation of lipase activity (GO:0060192) | 2.83275604 |
| 79 | detection of other organism (GO:0098543) | 2.80687031 |
| 80 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.80211411 |
| 81 | diacylglycerol metabolic process (GO:0046339) | 2.79935340 |
| 82 | phenylpropanoid metabolic process (GO:0009698) | 2.76517751 |
| 83 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.74803116 |
| 84 | negative regulation of cell killing (GO:0031342) | 2.74803116 |
| 85 | lipoprotein metabolic process (GO:0042157) | 2.74379606 |
| 86 | phospholipid homeostasis (GO:0055091) | 2.73235122 |
| 87 | regulation of cholesterol transport (GO:0032374) | 2.72739420 |
| 88 | regulation of sterol transport (GO:0032371) | 2.72739420 |
| 89 | response to mercury ion (GO:0046689) | 2.71713488 |
| 90 | intestinal cholesterol absorption (GO:0030299) | 2.71457370 |
| 91 | oxidative demethylation (GO:0070989) | 2.69176696 |
| 92 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.68582153 |
| 93 | acute inflammatory response (GO:0002526) | 2.67342291 |
| 94 | regulation of apoptotic cell clearance (GO:2000425) | 2.67157754 |
| 95 | immunoglobulin mediated immune response (GO:0016064) | 2.67036483 |
| 96 | negative regulation of wound healing (GO:0061045) | 2.64697749 |
| 97 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.63773934 |
| 98 | amino-acid betaine metabolic process (GO:0006577) | 2.62168116 |
| 99 | alkaloid metabolic process (GO:0009820) | 2.61406611 |
| 100 | flavonoid metabolic process (GO:0009812) | 2.59840906 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.28117919 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.30846245 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.66629062 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.38233708 |
| 5 | * PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.24973942 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.94221139 |
| 7 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.89410632 |
| 8 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.82332285 |
| 9 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.75699696 |
| 10 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.39787116 |
| 11 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.37298822 |
| 12 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.31613793 |
| 13 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.25293374 |
| 14 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.18374388 |
| 15 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.06792483 |
| 16 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.03693034 |
| 17 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.02680966 |
| 18 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.01158965 |
| 19 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.99183410 |
| 20 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.92575577 |
| 21 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.76589892 |
| 22 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.76032464 |
| 23 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.74113591 |
| 24 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.71216054 |
| 25 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.69389435 |
| 26 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.66785318 |
| 27 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.55522290 |
| 28 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.49028960 |
| 29 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.48123887 |
| 30 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.44373734 |
| 31 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.43620314 |
| 32 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.43034340 |
| 33 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.42598413 |
| 34 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.41401604 |
| 35 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.40927506 |
| 36 | MAF_26560356_Chip-Seq_TH1_Human | 1.40649926 |
| 37 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.40402571 |
| 38 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.39830100 |
| 39 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.38796800 |
| 40 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.38561547 |
| 41 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.37189497 |
| 42 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.34907229 |
| 43 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.33831685 |
| 44 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.32158906 |
| 45 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.31802990 |
| 46 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.31678304 |
| 47 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.31171454 |
| 48 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.31126582 |
| 49 | UTX_26944678_Chip-Seq_JUKART_Human | 1.29503311 |
| 50 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.28667719 |
| 51 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.28105668 |
| 52 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.26466811 |
| 53 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.25444876 |
| 54 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.25010357 |
| 55 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.24566144 |
| 56 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.23392824 |
| 57 | P68_20966046_ChIP-Seq_HELA_Human | 1.23311864 |
| 58 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.22292681 |
| 59 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.22074701 |
| 60 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.22030707 |
| 61 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.21812625 |
| 62 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.20836707 |
| 63 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.19868850 |
| 64 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.19062052 |
| 65 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.18023537 |
| 66 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.16920312 |
| 67 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.16138203 |
| 68 | GATA1_19941826_ChIP-Seq_K562_Human | 1.12466613 |
| 69 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.12414077 |
| 70 | MYC_22102868_ChIP-Seq_BL_Human | 1.11461675 |
| 71 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.10484120 |
| 72 | * SMC4_20622854_ChIP-Seq_HELA_Human | 1.10037855 |
| 73 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.09013548 |
| 74 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.08799597 |
| 75 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.08032050 |
| 76 | * MAF_26560356_Chip-Seq_TH2_Human | 1.07669289 |
| 77 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.06337276 |
| 78 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.06283650 |
| 79 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.04625111 |
| 80 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.03595927 |
| 81 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.02694493 |
| 82 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.02296103 |
| 83 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.01910662 |
| 84 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.01718508 |
| 85 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.01700245 |
| 86 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.01687305 |
| 87 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.01498520 |
| 88 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.00981356 |
| 89 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.00740865 |
| 90 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.00024397 |
| 91 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.99975342 |
| 92 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.98532465 |
| 93 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.98395314 |
| 94 | P300_27268052_Chip-Seq_Bcells_Human | 0.98233965 |
| 95 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.97544937 |
| 96 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.96644880 |
| 97 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.96608079 |
| 98 | * SPI1_20517297_ChIP-Seq_HL60_Human | 0.96323556 |
| 99 | SA1_27219007_Chip-Seq_Bcells_Human | 0.96011511 |
| 100 | MYB_26560356_Chip-Seq_TH2_Human | 0.94977958 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 6.10647135 |
| 2 | MP0005360_urolithiasis | 4.97037503 |
| 3 | MP0005365_abnormal_bile_salt | 3.97059730 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 3.87391731 |
| 5 | MP0009840_abnormal_foam_cell | 3.45589334 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 3.16359897 |
| 7 | MP0003191_abnormal_cellular_cholesterol | 2.97571140 |
| 8 | MP0002138_abnormal_hepatobiliary_system | 2.76123200 |
| 9 | MP0003436_decreased_susceptibility_to | 2.64888336 |
| 10 | MP0003195_calcinosis | 2.63537880 |
| 11 | MP0005058_abnormal_lysosome_morphology | 2.53433768 |
| 12 | MP0010329_abnormal_lipoprotein_level | 2.46632440 |
| 13 | MP0001666_abnormal_nutrient_absorption | 2.31660568 |
| 14 | MP0003724_increased_susceptibility_to | 2.31405408 |
| 15 | MP0003303_peritoneal_inflammation | 2.22276125 |
| 16 | MP0003252_abnormal_bile_duct | 2.22061123 |
| 17 | MP0005464_abnormal_platelet_physiology | 2.18527185 |
| 18 | MP0005451_abnormal_body_composition | 2.11200424 |
| 19 | MP0001835_abnormal_antigen_presentation | 2.04194023 |
| 20 | MP0009785_altered_susceptibility_to | 1.97093269 |
| 21 | MP0003172_abnormal_lysosome_physiology | 1.87353186 |
| 22 | MP0002419_abnormal_innate_immunity | 1.86993753 |
| 23 | MP0005025_abnormal_response_to | 1.85347811 |
| 24 | MP0003806_abnormal_nucleotide_metabolis | 1.76151411 |
| 25 | MP0003868_abnormal_feces_composition | 1.69243386 |
| 26 | MP0000685_abnormal_immune_system | 1.68977528 |
| 27 | MP0001790_abnormal_immune_system | 1.63922163 |
| 28 | MP0005387_immune_system_phenotype | 1.63922163 |
| 29 | MP0001800_abnormal_humoral_immune | 1.61908846 |
| 30 | MP0000609_abnormal_liver_physiology | 1.60690864 |
| 31 | MP0002118_abnormal_lipid_homeostasis | 1.60641984 |
| 32 | MP0005000_abnormal_immune_tolerance | 1.59164749 |
| 33 | MP0002132_abnormal_respiratory_system | 1.58479804 |
| 34 | MP0003183_abnormal_peptide_metabolism | 1.55909699 |
| 35 | MP0005332_abnormal_amino_acid | 1.52916998 |
| 36 | MP0002876_abnormal_thyroid_physiology | 1.50197864 |
| 37 | MP0005671_abnormal_response_to | 1.49487313 |
| 38 | MP0010155_abnormal_intestine_physiology | 1.48971551 |
| 39 | MP0006082_CNS_inflammation | 1.46821555 |
| 40 | MP0008469_abnormal_protein_level | 1.45197125 |
| 41 | MP0000604_amyloidosis | 1.43388413 |
| 42 | MP0002148_abnormal_hypersensitivity_rea | 1.40622048 |
| 43 | MP0002723_abnormal_immune_serum | 1.39756031 |
| 44 | MP0008260_abnormal_autophagy | 1.36119184 |
| 45 | MP0003300_gastrointestinal_ulcer | 1.35325414 |
| 46 | MP0001533_abnormal_skeleton_physiology | 1.34168855 |
| 47 | MP0009764_decreased_sensitivity_to | 1.30324644 |
| 48 | MP0002452_abnormal_antigen_presenting | 1.29788620 |
| 49 | MP0001845_abnormal_inflammatory_respons | 1.28866972 |
| 50 | MP0003075_altered_response_to | 1.24371821 |
| 51 | MP0001764_abnormal_homeostasis | 1.23750563 |
| 52 | MP0002420_abnormal_adaptive_immunity | 1.22981075 |
| 53 | MP0001819_abnormal_immune_cell | 1.22426596 |
| 54 | MP0005319_abnormal_enzyme/_coenzyme | 1.17969511 |
| 55 | MP0009643_abnormal_urine_homeostasis | 1.16287614 |
| 56 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.15823300 |
| 57 | MP0004019_abnormal_vitamin_homeostasis | 1.15495053 |
| 58 | MP0004947_skin_inflammation | 1.12334878 |
| 59 | MP0009333_abnormal_splenocyte_physiolog | 1.10241093 |
| 60 | MP0003866_abnormal_defecation | 1.09270774 |
| 61 | MP0003879_abnormal_hair_cell | 1.08257553 |
| 62 | MP0003690_abnormal_glial_cell | 1.06752647 |
| 63 | MP0005670_abnormal_white_adipose | 1.05120004 |
| 64 | MP0003656_abnormal_erythrocyte_physiolo | 1.04824224 |
| 65 | MP0000858_altered_metastatic_potential | 1.04556276 |
| 66 | MP0005166_decreased_susceptibility_to | 1.03241853 |
| 67 | MP0009763_increased_sensitivity_to | 1.00468845 |
| 68 | MP0002971_abnormal_brown_adipose | 0.97827223 |
| 69 | MP0000716_abnormal_immune_system | 0.92886559 |
| 70 | MP0003329_amyloid_beta_deposits | 0.91042937 |
| 71 | MP0009642_abnormal_blood_homeostasis | 0.90526729 |
| 72 | MP0002405_respiratory_system_inflammati | 0.88404326 |
| 73 | MP0000465_gastrointestinal_hemorrhage | 0.85079698 |
| 74 | MP0000598_abnormal_liver_morphology | 0.84202854 |
| 75 | MP0001545_abnormal_hematopoietic_system | 0.84153499 |
| 76 | MP0005397_hematopoietic_system_phenotyp | 0.84153499 |
| 77 | MP0000689_abnormal_spleen_morphology | 0.83418440 |
| 78 | MP0000249_abnormal_blood_vessel | 0.82873506 |
| 79 | MP0004883_abnormal_blood_vessel | 0.81183395 |
| 80 | MP0003763_abnormal_thymus_physiology | 0.80018852 |
| 81 | MP0002398_abnormal_bone_marrow | 0.79493606 |
| 82 | MP0005535_abnormal_body_temperature | 0.78754133 |
| 83 | MP0001851_eye_inflammation | 0.76365784 |
| 84 | MP0002998_abnormal_bone_remodeling | 0.75557148 |
| 85 | MP0005636_abnormal_mineral_homeostasis | 0.74151013 |
| 86 | MP0005334_abnormal_fat_pad | 0.72597736 |
| 87 | MP0005164_abnormal_response_to | 0.72255068 |
| 88 | MP0002429_abnormal_blood_cell | 0.72074852 |
| 89 | MP0004130_abnormal_muscle_cell | 0.71629241 |
| 90 | MP0002722_abnormal_immune_system | 0.71526035 |
| 91 | MP0005666_abnormal_adipose_tissue | 0.70912603 |
| 92 | MP0001663_abnormal_digestive_system | 0.70555629 |
| 93 | MP0005376_homeostasis/metabolism_phenot | 0.69008871 |
| 94 | MP0005167_abnormal_blood-brain_barrier | 0.68438930 |
| 95 | MP0004510_myositis | 0.67895035 |
| 96 | MP0000343_altered_response_to | 0.67404500 |
| 97 | MP0008874_decreased_physiological_sensi | 0.67143037 |
| 98 | MP0003828_pulmonary_edema | 0.64796846 |
| 99 | MP0001853_heart_inflammation | 0.64756617 |
| 100 | MP0002136_abnormal_kidney_physiology | 0.63449331 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 6.31123438 |
| 2 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.99946005 |
| 3 | Complement deficiency (HP:0004431) | 5.71799448 |
| 4 | Systemic lupus erythematosus (HP:0002725) | 5.53478318 |
| 5 | Hypobetalipoproteinemia (HP:0003563) | 4.85178982 |
| 6 | Abnormality of complement system (HP:0005339) | 4.84264503 |
| 7 | Prolonged partial thromboplastin time (HP:0003645) | 4.69399904 |
| 8 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.66581763 |
| 9 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.45673423 |
| 10 | Joint hemorrhage (HP:0005261) | 4.43536679 |
| 11 | Glomerulonephritis (HP:0000099) | 4.06958468 |
| 12 | Xanthomatosis (HP:0000991) | 4.01318888 |
| 13 | Hyperlipoproteinemia (HP:0010980) | 3.83944073 |
| 14 | Eczematoid dermatitis (HP:0000976) | 3.80525114 |
| 15 | Gingival bleeding (HP:0000225) | 3.74486582 |
| 16 | Hemorrhage of the eye (HP:0011885) | 3.58132778 |
| 17 | Purpura (HP:0000979) | 3.56552100 |
| 18 | Abnormality of the common coagulation pathway (HP:0010990) | 3.51509292 |
| 19 | Conjugated hyperbilirubinemia (HP:0002908) | 3.43668153 |
| 20 | Abnormality of macrophages (HP:0004311) | 3.19609255 |
| 21 | Myositis (HP:0100614) | 3.13069526 |
| 22 | Orchitis (HP:0100796) | 3.03281328 |
| 23 | Nephritis (HP:0000123) | 2.97458392 |
| 24 | Epistaxis (HP:0000421) | 2.95606160 |
| 25 | Spontaneous abortion (HP:0005268) | 2.95508395 |
| 26 | Recurrent abscess formation (HP:0002722) | 2.89345657 |
| 27 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.87709065 |
| 28 | Amyloidosis (HP:0011034) | 2.86108001 |
| 29 | Hypolipoproteinemia (HP:0010981) | 2.85333262 |
| 30 | Optic neuritis (HP:0100653) | 2.74472487 |
| 31 | Retrobulbar optic neuritis (HP:0100654) | 2.74472487 |
| 32 | Increased serum ferritin (HP:0003281) | 2.72106129 |
| 33 | Pulmonary embolism (HP:0002204) | 2.71925620 |
| 34 | Intrahepatic cholestasis (HP:0001406) | 2.71798479 |
| 35 | Prolonged bleeding time (HP:0003010) | 2.70194868 |
| 36 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.61214719 |
| 37 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.59984744 |
| 38 | Menorrhagia (HP:0000132) | 2.57927833 |
| 39 | Thrombophlebitis (HP:0004418) | 2.57205584 |
| 40 | Obstructive lung disease (HP:0006536) | 2.56222568 |
| 41 | Chronic obstructive pulmonary disease (HP:0006510) | 2.56222568 |
| 42 | Recurrent bacterial skin infections (HP:0005406) | 2.53913666 |
| 43 | Dysostosis multiplex (HP:0000943) | 2.52375026 |
| 44 | Meningitis (HP:0001287) | 2.50911024 |
| 45 | Abnormality of iron homeostasis (HP:0011031) | 2.48606026 |
| 46 | Fat malabsorption (HP:0002630) | 2.48117821 |
| 47 | Joint swelling (HP:0001386) | 2.47973588 |
| 48 | Hyperammonemia (HP:0001987) | 2.44440207 |
| 49 | Gastrointestinal infarctions (HP:0005244) | 2.43082262 |
| 50 | Petechiae (HP:0000967) | 2.39085732 |
| 51 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.34537937 |
| 52 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.34537937 |
| 53 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.34537937 |
| 54 | Myocardial infarction (HP:0001658) | 2.31382902 |
| 55 | Mitral stenosis (HP:0001718) | 2.30370153 |
| 56 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.30180200 |
| 57 | Mucopolysacchariduria (HP:0008155) | 2.30180200 |
| 58 | Malnutrition (HP:0004395) | 2.27970782 |
| 59 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.26522307 |
| 60 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.25995195 |
| 61 | Gangrene (HP:0100758) | 2.25772443 |
| 62 | Vasculitis (HP:0002633) | 2.21935466 |
| 63 | Vacuolated lymphocytes (HP:0001922) | 2.19206735 |
| 64 | Hypercholesterolemia (HP:0003124) | 2.18360735 |
| 65 | Mediastinal lymphadenopathy (HP:0100721) | 2.16035961 |
| 66 | Gingivitis (HP:0000230) | 2.11791236 |
| 67 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.11483341 |
| 68 | Abnormality of glycolipid metabolism (HP:0010969) | 2.11483341 |
| 69 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.11483341 |
| 70 | Increased cerebral lipofuscin (HP:0011813) | 2.08903417 |
| 71 | Epidermoid cyst (HP:0200040) | 2.06124085 |
| 72 | Hypertriglyceridemia (HP:0002155) | 2.04884890 |
| 73 | Impaired platelet aggregation (HP:0003540) | 2.04007983 |
| 74 | Abnormal platelet function (HP:0011869) | 2.04007983 |
| 75 | Vascular calcification (HP:0004934) | 2.02249778 |
| 76 | Recurrent fungal infections (HP:0002841) | 1.93744232 |
| 77 | Arterial thrombosis (HP:0004420) | 1.92676438 |
| 78 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.92553884 |
| 79 | Generalized aminoaciduria (HP:0002909) | 1.91931461 |
| 80 | Pulmonary infiltrates (HP:0002113) | 1.90810887 |
| 81 | Polycythemia (HP:0001901) | 1.90354548 |
| 82 | Rickets (HP:0002748) | 1.89969560 |
| 83 | Steatorrhea (HP:0002570) | 1.88515043 |
| 84 | Urticaria (HP:0001025) | 1.88303231 |
| 85 | Anorexia (HP:0002039) | 1.86729452 |
| 86 | Hypoalphalipoproteinemia (HP:0003233) | 1.86497254 |
| 87 | Cellulitis (HP:0100658) | 1.86260142 |
| 88 | Encephalitis (HP:0002383) | 1.84950439 |
| 89 | Recurrent skin infections (HP:0001581) | 1.84030006 |
| 90 | Hypochromic anemia (HP:0001931) | 1.83840615 |
| 91 | Polygenic inheritance (HP:0010982) | 1.82413518 |
| 92 | Hemoptysis (HP:0002105) | 1.80899610 |
| 93 | Keratoconjunctivitis sicca (HP:0001097) | 1.80554886 |
| 94 | Skin rash (HP:0000988) | 1.80413261 |
| 95 | Abnormal gallbladder physiology (HP:0012438) | 1.78625943 |
| 96 | Cholecystitis (HP:0001082) | 1.78625943 |
| 97 | Spontaneous hematomas (HP:0007420) | 1.78561942 |
| 98 | Abnormal platelet volume (HP:0011876) | 1.78125752 |
| 99 | Pancreatitis (HP:0001733) | 1.76661982 |
| 100 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.76587400 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 4.64145076 |
| 2 | RIPK4 | 3.54387580 |
| 3 | MAP4K1 | 2.55668197 |
| 4 | TYK2 | 2.55168274 |
| 5 | TRIB3 | 2.40629532 |
| 6 | FGFR4 | 2.34488223 |
| 7 | BLK | 2.14511821 |
| 8 | MAP2K3 | 2.07780017 |
| 9 | PRPF4B | 2.00649334 |
| 10 | TBK1 | 1.87909676 |
| 11 | GRK6 | 1.87588534 |
| 12 | MAP3K3 | 1.82258161 |
| 13 | MAP3K11 | 1.74058575 |
| 14 | IRAK4 | 1.73170275 |
| 15 | RIPK1 | 1.71468945 |
| 16 | ZAP70 | 1.70987012 |
| 17 | TNK2 | 1.65755200 |
| 18 | TESK2 | 1.65044458 |
| 19 | EPHB1 | 1.60237087 |
| 20 | CSK | 1.58136794 |
| 21 | FES | 1.53895574 |
| 22 | MAP3K14 | 1.48087282 |
| 23 | CSF1R | 1.45689597 |
| 24 | TAOK1 | 1.36914628 |
| 25 | SIK1 | 1.33825712 |
| 26 | SYK | 1.33683557 |
| 27 | BTK | 1.31220861 |
| 28 | PDPK1 | 1.31064507 |
| 29 | MAP3K1 | 1.29990571 |
| 30 | SIK2 | 1.29434935 |
| 31 | IKBKE | 1.28945073 |
| 32 | JAK3 | 1.25875495 |
| 33 | TXK | 1.23321534 |
| 34 | PKN2 | 1.18791743 |
| 35 | MAP3K13 | 1.17704812 |
| 36 | JAK1 | 1.17223242 |
| 37 | MATK | 1.15704921 |
| 38 | PDK1 | 1.15605566 |
| 39 | TAOK2 | 1.15263749 |
| 40 | EPHA3 | 1.12651158 |
| 41 | JAK2 | 1.10860912 |
| 42 | IRAK3 | 1.10042836 |
| 43 | KIT | 1.05860503 |
| 44 | FGFR3 | 1.05715942 |
| 45 | HCK | 1.05243956 |
| 46 | FGR | 1.02502139 |
| 47 | IKBKB | 1.01327567 |
| 48 | MAPK11 | 1.00780573 |
| 49 | PIK3CG | 1.00173364 |
| 50 | LYN | 0.99952853 |
| 51 | TAOK3 | 0.97203498 |
| 52 | KSR2 | 0.92328266 |
| 53 | LCK | 0.89098398 |
| 54 | ITK | 0.89076134 |
| 55 | PIM2 | 0.88825322 |
| 56 | MAPKAPK3 | 0.87679777 |
| 57 | PRKD2 | 0.86509191 |
| 58 | PTK6 | 0.85956940 |
| 59 | BCKDK | 0.82436139 |
| 60 | CDC42BPA | 0.82040896 |
| 61 | RET | 0.80317782 |
| 62 | DYRK1B | 0.78054072 |
| 63 | STK38 | 0.77704081 |
| 64 | BMPR2 | 0.77220622 |
| 65 | ICK | 0.76649787 |
| 66 | TGFBR2 | 0.75168218 |
| 67 | SMG1 | 0.72565373 |
| 68 | PRKAA2 | 0.71347898 |
| 69 | TESK1 | 0.71140782 |
| 70 | MAPK12 | 0.68490156 |
| 71 | ARAF | 0.68392499 |
| 72 | KDR | 0.67000724 |
| 73 | MAP2K2 | 0.66048751 |
| 74 | MARK2 | 0.65955013 |
| 75 | PIK3CA | 0.63106199 |
| 76 | IRAK1 | 0.61839071 |
| 77 | MAP3K6 | 0.61073169 |
| 78 | MAP2K6 | 0.56552608 |
| 79 | SIK3 | 0.56032253 |
| 80 | MAP3K2 | 0.55907585 |
| 81 | ABL2 | 0.52812340 |
| 82 | DAPK2 | 0.51583433 |
| 83 | FYN | 0.51334251 |
| 84 | CAMKK1 | 0.50847232 |
| 85 | MARK3 | 0.50261829 |
| 86 | CAMKK2 | 0.50198431 |
| 87 | HIPK2 | 0.49147606 |
| 88 | MYLK | 0.47959596 |
| 89 | TEC | 0.47892258 |
| 90 | PRKD1 | 0.47664010 |
| 91 | PRKACG | 0.47616406 |
| 92 | MAP3K5 | 0.47285665 |
| 93 | PRKCQ | 0.44506099 |
| 94 | CDK12 | 0.40829121 |
| 95 | PRKCZ | 0.40802153 |
| 96 | PRKG2 | 0.40014201 |
| 97 | MAPK7 | 0.40000424 |
| 98 | LRRK2 | 0.37474304 |
| 99 | MAP3K7 | 0.34555679 |
| 100 | IGF1R | 0.33208430 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 3.46133960 |
| 2 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.98521678 |
| 3 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.93477172 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.92900077 |
| 5 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.80984181 |
| 6 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.57697756 |
| 7 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.47680445 |
| 8 | Retinol metabolism_Homo sapiens_hsa00830 | 2.44917803 |
| 9 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.25411121 |
| 10 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.22258496 |
| 11 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 2.12863093 |
| 12 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 2.08716100 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.04361558 |
| 14 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.01926442 |
| 15 | * Fatty acid degradation_Homo sapiens_hsa00071 | 2.01019413 |
| 16 | Histidine metabolism_Homo sapiens_hsa00340 | 1.92367032 |
| 17 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.91916844 |
| 18 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.80886181 |
| 19 | * PPAR signaling pathway_Homo sapiens_hsa03320 | 1.78319817 |
| 20 | Other glycan degradation_Homo sapiens_hsa00511 | 1.75769248 |
| 21 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.72122365 |
| 22 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.71827704 |
| 23 | Bile secretion_Homo sapiens_hsa04976 | 1.48165219 |
| 24 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.47762735 |
| 25 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.44054168 |
| 26 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.41560212 |
| 27 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.37328749 |
| 28 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.37295440 |
| 29 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.35916612 |
| 30 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.34770495 |
| 31 | Allograft rejection_Homo sapiens_hsa05330 | 1.28687087 |
| 32 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.22408748 |
| 33 | Leishmaniasis_Homo sapiens_hsa05140 | 1.21220588 |
| 34 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.21159625 |
| 35 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.17167051 |
| 36 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.11958348 |
| 37 | * Peroxisome_Homo sapiens_hsa04146 | 1.09228339 |
| 38 | Asthma_Homo sapiens_hsa05310 | 1.06027320 |
| 39 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.02584494 |
| 40 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.92582619 |
| 41 | Pertussis_Homo sapiens_hsa05133 | 0.91765591 |
| 42 | Prion diseases_Homo sapiens_hsa05020 | 0.91181595 |
| 43 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.90534209 |
| 44 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.89148706 |
| 45 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.86685733 |
| 46 | * Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.85922450 |
| 47 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.83991472 |
| 48 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.80570490 |
| 49 | ABC transporters_Homo sapiens_hsa02010 | 0.79940801 |
| 50 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.79764971 |
| 51 | * Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.79506706 |
| 52 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.75671925 |
| 53 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.74177554 |
| 54 | * Fatty acid metabolism_Homo sapiens_hsa01212 | 0.73895302 |
| 55 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.72489583 |
| 56 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.71859486 |
| 57 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.71650952 |
| 58 | Tuberculosis_Homo sapiens_hsa05152 | 0.69175252 |
| 59 | Lysosome_Homo sapiens_hsa04142 | 0.67243686 |
| 60 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.64767944 |
| 61 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.64532214 |
| 62 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.63968364 |
| 63 | Carbon metabolism_Homo sapiens_hsa01200 | 0.63230380 |
| 64 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.62937801 |
| 65 | Galactose metabolism_Homo sapiens_hsa00052 | 0.62141711 |
| 66 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.60621073 |
| 67 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.60382767 |
| 68 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.59746339 |
| 69 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.58972518 |
| 70 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.58914512 |
| 71 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.58811018 |
| 72 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.55944256 |
| 73 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.53951346 |
| 74 | Insulin resistance_Homo sapiens_hsa04931 | 0.53863745 |
| 75 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.53555371 |
| 76 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.52149795 |
| 77 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.50278924 |
| 78 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.49869893 |
| 79 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.47667744 |
| 80 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.47379960 |
| 81 | Phagosome_Homo sapiens_hsa04145 | 0.46321505 |
| 82 | Viral myocarditis_Homo sapiens_hsa05416 | 0.44721646 |
| 83 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.42412565 |
| 84 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.42152778 |
| 85 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.41598123 |
| 86 | Sulfur relay system_Homo sapiens_hsa04122 | 0.41553771 |
| 87 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.39909762 |
| 88 | Influenza A_Homo sapiens_hsa05164 | 0.39669380 |
| 89 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.39120026 |
| 90 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.37953510 |
| 91 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.36833455 |
| 92 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.36205053 |
| 93 | Hepatitis C_Homo sapiens_hsa05160 | 0.34412677 |
| 94 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.34066351 |
| 95 | Mineral absorption_Homo sapiens_hsa04978 | 0.31268007 |
| 96 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.29900740 |
| 97 | * alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.28505914 |
| 98 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.28496252 |
| 99 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.28004714 |
| 100 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.27485495 |

